University of Arizona Cancer Center researchers discovered that cancer cells in men selectively erode gene-rich regions of the Y chromosome, triggering stress, growth, and immune responses that drive tumor development. The study, published in 2026, maps this Y chromosome erosion as a continuous gradient rather than a simple all-or-nothing loss.
Mapping the Gradual Erosion of the Y Chromosome in Cancer Cells
Each cell in a man’s body typically carries one X and one Y chromosome. While the Y chromosome is historically recognized for determining male sex, scientists are uncovering additional roles for its genes across tissues throughout the body. The loss of this chromosome is a familiar genetic shift in aging men, frequently noted in blood cells.
Co-led by University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu, researchers analyzed genome sequencing and gene expression data drawn from 160 male cell lines within the Cancer Cell Line Encyclopedia. To bypass non-cancerous background cells that can obscure genetic signals in raw tumor samples, the team focused directly on cancer cell lines. They deployed a novel scoring system called the Y EroSion Score, or YES, which allowed them to evaluate Y chromosome loss as a continuous spectrum of wear rather than an absolute binary state.
Identifying Recurrent Gene Losses Across Human Organs
The research team identified 24 protein-coding genes on the Y chromosome that were recurrently lost in cancer cell lines. Among those, 15 genes also appeared lost in at least one of two external datasets: single-nucleus sequencing of bladder tumors and a pan-cancer clinical sequencing panel. When investigators cross-referenced their findings against genome sequencing data from healthy men in the 1000 Genomes Project, they found zero evidence of identical Y chromosome deletions, confirming that these losses are acquired over time rather than inherited as traits.
In a separate phase of the work, investigators examined 1,000 tissue samples taken from 405 men, utilizing an automated fluorescent imaging system to inspect more than 4.3 million individual cell nuclei and measure the ratio of Y to X chromosomes. Researchers built detailed maps of bladder tissue removed during cancer surgery. Those maps illustrated how Y chromosome loss intensified progressively from normal tissue through early abnormal cells and into full-blown cancer. The highest rates of Y loss in normal-appearing tissue turned up in colon, rectum, esophagus, pancreas, and lung cancers.
Implications for Early Detection and Future Target Therapies
The discovery that Y chromosome erosion appears in normal-appearing tissue adjacent to tumors suggests a pre-neoplastic field effect—a hidden zone of genetic vulnerability that creates fertile ground for malignancy. Researchers view this progression as a gradient comparable to a hillside that slowly steepens, where tissue located closer to a tumor displays heavier Y chromosome loss.
